Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published December 2016 | Published
Journal Article Open

The balance between N-cadherin and E-cadherin orchestrates major neuroectodermal cell fate choices

Abstract

Numerous cadherin proteins, including N‐cadherin (Ncad), E‐cadherin (Ecad), Cadherin‐11 (Cad11) and Cadherin‐7 (Cad7), are expressed in the developing neural plate as well as in neural crest cells as they delaminate from the newly closed neural tube. To clarify whether these proteins function independently or coordinately during development, we examined their relative expression in the cranial region of chick embryos. The results revealed surprising overlap of Ecad, Ncad and Cad7 in the neural tube, suggesting possible heterotypic interactions. Using a proximity ligation assay and co‐immunoprecipitation to test this hypothesis, we found that Ncad formed heterophilic complexes in the developing neural tube with Ecad. We also determined that modulation of either Ncad or Ecad levels led to reciprocal gain or reduction of the other cadherin protein. Altering levels of the two cadherin proteins affected the early fate specification of ectodermal derivatives, forcing an aberrant choice between neural crest and epidermal cells. Finally, we identified that the availability of β‐catenin plays a critical role in maintaining the balance between Ncad and Ecad in early development since co‐expression of activated β‐catenin rescues the Ncad‐overexpression phenotype. These results suggest that β‐catenin‐mediated balance of Ncad and Ecad proteins is critical for the normal development of the three ectodermal derivatives.

Additional Information

© 2016 American Society for Cell Biology.

Attached Files

Published - Rogers_2016pP762.pdf

Files

Rogers_2016pP762.pdf
Files (115.0 kB)
Name Size Download all
md5:0317f4414da510c723ee09d317755df3
115.0 kB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 25, 2023